Combination lipid-lowering therapy
1 paper1 finding
- 1 lab in 1 country
- Humans1
Outcomes
1LDL-C target attainment
upin humans1OR 5.7
1 study
LDL-C target attainment
upin humans1OR 5.7
Combination lipid-lowering therapy increases LDL-C target attainment in humans (OR 5.7, 95% CI 3.7-9.0).
Humansin people with HIV ≥40 yearsn = 588
AIDS (London, England)19 Aug 2026